Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cerdulatinib Gel in Adults With Vitiligo
NCT04103060Phase 2Completed
- Sponsor
- Dermavant Sciences
- Start
- Sep 2019
- Primary completion
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Vitiligo comparing Cerdulatinib 0.37% gel with Vehicle gel (2 arms). Primary endpoints: Vital signs at Week 7, Laboratory Values at Week 7 and 2 more. Started Sep 2019; status: completed.
02
Drugs
cerdulatinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT04103060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04103060.